Revolution Medicines Stock Investor Sentiment
RVMD Stock | USD 37.22 0.31 0.83% |
About 75% of Revolution Medicines' investor base is looking to short. The analysis of the overall investor sentiment regarding Revolution Medicines suggests that many traders are alarmed. The current market sentiment, together with Revolution Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Revolution Medicines stock news signals to limit their universe of possible portfolio assets.
Comfort Level 25
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Revolution Medicines' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Revolution Medicines.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
Revolution Historical Sentiment
Although Revolution Medicines' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Revolution, such as negative comments on social media and news outlets, may cause fear in the market and push Revolution Medicines' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Revolution.
Revolution | Build AI portfolio with Revolution Stock |
Revolution Medicines Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Revolution Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Revolution Medicines Historical Investor Sentiment
Investor biases related to Revolution Medicines' public news can be used to forecast risks associated with an investment in Revolution. The trend in average sentiment can be used to explain how an investor holding Revolution can time the market purely based on public headlines and social activities around Revolution Medicines. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Revolution Medicines' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Revolution Medicines and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Revolution Medicines news discussions. The higher the estimate score, the more favorable the investor's outlook on Revolution Medicines.
Revolution Medicines Maximum Pain Price Across October 17th 2025 Option Contracts
Revolution Medicines' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Revolution Medicines close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Revolution Medicines' options.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Revolution Medicines' Stock prices. Below is the latest headlines and news related to Revolution Medicines Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Revolution Medicines that are available to investors today. This information is accessible both publicly - through Revolution Medicines' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Revolution-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Revolution Medicines news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Revolution Medicines relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Revolution Medicines' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Revolution Medicines alpha.
Revolution Largest EPS Surprises
Earnings surprises can significantly impact Revolution Medicines' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2022-02-28 | 2021-12-31 | -0.64 | -0.71 | -0.07 | 10 | ||
2023-05-08 | 2023-03-31 | -0.81 | -0.72 | 0.09 | 11 | ||
2021-11-10 | 2021-09-30 | -0.63 | -0.72 | -0.09 | 14 | ||
2023-08-08 | 2023-06-30 | -0.82 | -0.92 | -0.1 | 12 | ||
2020-08-10 | 2020-06-30 | -0.36 | -0.46 | -0.1 | 27 | ||
2021-03-02 | 2020-12-31 | -0.38 | -0.52 | -0.14 | 36 |
There is far too much social signal, news, headlines, and media speculation about Revolution Medicines that are available to investors today. This information is accessible both publicly - through Revolution Medicines' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Revolution-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Revolution Medicines news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Revolution Medicines relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Revolution Medicines' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Revolution Medicines alpha.
Revolution Medicines Performance against Dow Jones
Price Growth (%) |
Timeline |
1 | Acquisition by Mark Goldsmith of 97400 shares of Revolution Medicines subject to Rule 16b-3 | 05/02/2025 |
2 | Revolution Medicines, Inc. Q1 2025 Earnings Call Transcript | 05/08/2025 |
3 | Disposition of 2173 shares by Wei Lin of Revolution Medicines at .83 subject to Rule 16b-3 | 06/12/2025 |
4 | Revolution Medicines Secures 2B Funding with Royalty Pharma Partnership | 06/24/2025 |
5 | Acquisition by Clyburn Frank of 2806 shares of Revolution Medicines subject to Rule 16b-3 | 06/26/2025 |
6 | Summit Therapeutics stock holds Buy rating at H.C. Wainwright on Revolution Medicines deal - Investing.com Nigeria | 07/01/2025 |
7 | Revolution Medicines, Summit Therapeutics Partner on RAS InhibitorIvonescimab Combinations for Solid Tumors - MSN | 07/07/2025 |
8 | Revolution Medicines Partners with Iambic for AI-Driven Drug Discovery RVMD Stock News | 07/09/2025 |
9 | What makes Revolution Medicines Inc. Equity Warrant stock price move sharply - Investor Friendly Risk Reward - beatles.ru | 07/14/2025 |
10 | Revolution Medicines Coverage Initiated by Goldman Sachs with Buy Rating RVMD Stock News | 07/15/2025 |
11 | What drives Revolution Medicines Inc. stock price - Market-beating performance - Jammu Links News | 07/18/2025 |
12 | What analysts say about Revolution Medicines Inc. stock - Free Bull Bear Market Updates - jammulinksnews.com | 07/22/2025 |
13 | Revolution Medicines Inc Unveils Breakthrough in Targeted Cancer Therapy RVMD stock news | 07/24/2025 |
Complementary Tools for Revolution Stock analysis
When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance |